InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Sherman Jeffrey W, Director. Insider active across 6 companies, notably Strongbridge Biopharma plc. Cumulatively, 30 disclosures have been recorded. Breakdown: 2 buys · 2 sells. Total volume traded: €4.6m. History available since 14 May 2021. The latest transaction was disclosed on 27 February 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Sherman Jeffrey W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations30 total
5,000 shares@ US$5.00100.0% of flowCommon StockSEC:0001193125-26-085510:0
Canonical exit: 28 May 2026 (T+90)
47,040 shares@ US$6.6696.7% of flowCommon StockSEC:0001867096-25-000145:0
50,000 shares0Common StockSEC:0001867096-25-000110:0
50,000 shares0Common StockSEC:0001867096-24-000108:0
6,502 sharesCommon StockSEC:0001867096-24-000043:0
5,400 shares@ US$1.87100.0% of flowCommon StockSEC:0001867096-23-000154:0
Canonical exit: 25 Feb 2024 (T+90)
2,655 shares@ US$116.505.8% of flowOrdinary SharesSEC:0001209191-23-052358:0
2,165 shares0Ordinary SharesSEC:0001209191-23-048609:0
42,500 shares0Common StockSEC:0001867096-23-000091:0
33,795 shares0Ordinary SharesSEC:0001209191-23-003738:0
3,368 shares@ US$113.057.1% of flowOrdinary SharesSEC:0001209191-23-003146:0
51,132 sharesOrdinary SharesSEC:0001209191-23-002439:0
21,772 sharesOrdinary SharesSEC:0001209191-23-000939:0
8,531 shares0Ordinary SharesSEC:0001209191-22-060901:0
15,000 shares0Common StockSEC:0001867096-22-000095:0
42,009 shares@ US$110.02196.8% of flowOrdinary SharesSEC:0001209191-22-023841:0
12,304 shares0Ordinary SharesSEC:0001209191-22-020259:0
5,354 shares0Ordinary SharesSEC:0001209191-22-004632:0
10,729 shares0Ordinary SharesSEC:0001209191-22-002285:0
10,729 shares@ US$7.611.4% of flowOrdinary SharesSEC:0001209191-21-062085:0
64,258 sharesOrdinary SharesSEC:0001179110-21-009279:0
50,378 sharesCommon StockSEC:0000899243-21-039322:0
17,763 shares@ US$2.0646.2% of flowOrdinary SharesSEC:0001179110-21-009221:0
4,042 shares0Ordinary SharesSEC:0001209191-21-057450:0
7,257 shares0Ordinary SharesSEC:0001209191-21-048791:0
25 of 30 declarations
About Sherman Jeffrey W
SHERMAN JEFFREY W is Director and Executive Vice President, Chief Medical Officer. He has 30 filings in total, and across the 30 sampled filings the transactions run from 2016-01-05 to 2026-03-02, with EUR 30411 of purchases and EUR 4888957 of sales; the filings relate to Horizon Therapeutics Public Ltd Co, Xeris Biopharma Holdings, Inc., Strongbridge Biopharma plc, Horizon Pharma plc and Larimar Therapeutics, Inc.
